NCT01383447 2017-08-08Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNational Cancer Institute (NCI)Phase 1/2 Terminated2 enrolled 4 charts